Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Treatment non-response in OCD: methodological issues and operational definitions.

Pallanti S, Hollander E, Bienstock C, Koran L, Leckman J, Marazziti D, Pato M, Stein D, Zohar J; International Treatment Refractory OCD Consortium.

Int J Neuropsychopharmacol. 2002 Jun;5(2):181-91. Review.

PMID:
12135542
2.

Treatment-refractory obsessive-compulsive disorder: methodological issues, operational definitions and therapeutic lines.

Pallanti S, Quercioli L.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 May;30(3):400-12. Epub 2006 Feb 28. Review.

PMID:
16503369
3.

A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.

Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF.

Mol Psychiatry. 2006 Jul;11(7):622-32. Epub 2006 Apr 4. Review. Erratum in: Mol Psychiatry. 2006 Aug;11(8):795.

PMID:
16585942
4.

Clinical predictors of drug nonresponse in obsessive-compulsive disorder.

Shetti CN, Reddy YC, Kandavel T, Kashyap K, Singisetti S, Hiremath AS, Siddequehusen MU, Raghunandanan S.

J Clin Psychiatry. 2005 Dec;66(12):1517-23.

PMID:
16401151
5.

Meta-analysis of pharmacotherapy trials for obsessive-compulsive disorder.

Stein DJ, Spadaccini E, Hollander E.

Int Clin Psychopharmacol. 1995 Mar;10(1):11-8.

PMID:
7622800
6.

Clinical predictors of response to pharmacotherapy with selective serotonin reuptake inhibitors in obsessive-compulsive disorder.

Tükel R, Bozkurt O, Polat A, Genç A, Atli H.

Psychiatry Clin Neurosci. 2006 Aug;60(4):404-9.

7.

Issues in the pharmacological treatment of obsessive-compulsive disorder.

Math SB, Janardhan Reddy YC.

Int J Clin Pract. 2007 Jul;61(7):1188-97. Epub 2007 May 18. Review.

PMID:
17511795
8.

Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?

Geller DA, Biederman J, Stewart SE, Mullin B, Farrell C, Wagner KD, Emslie G, Carpenter D.

J Child Adolesc Psychopharmacol. 2003;13 Suppl 1:S19-29.

PMID:
12880497
9.

The medical treatment of obsessive-compulsive disorder and anxiety.

Bandelow B.

CNS Spectr. 2008 Sep;13(9 Suppl 14):37-46. Review.

PMID:
18849910
10.

Pharmacotherapy in paediatric obsessive-compulsive disorder: a naturalistic, retrospective study.

Masi G, Millepiedi S, Perugi G, Pfanner C, Berloffa S, Pari C, Mucci M.

CNS Drugs. 2009;23(3):241-52. doi: 10.2165/00023210-200923030-00005.

PMID:
19320532
11.

Comparison of clinical characteristics and comorbidity in schizophrenia patients with and without obsessive-compulsive disorder: schizophrenic and OC symptoms in schizophrenia.

Poyurovsky M, Kriss V, Weisman G, Faragian S, Kurs R, Schneidman M, Fuchs C, Weizman A, Weizman R.

J Clin Psychiatry. 2003 Nov;64(11):1300-7.

PMID:
14658943
12.

[Clinical features of patients with obsessive-compulsive disorder showing different pharmacological responses].

Sumitani S, Ueno S, Ishimoto Y, Taniguchi T, Tomotake M, Motoki I, Yamauchi K, Ohmori T.

Seishin Shinkeigaku Zasshi. 2006;108(12):1282-92. Japanese.

PMID:
17334085
13.

[Critical analysis of controlled pharmacologic studies in obsessive compulsive disorder].

Brochier T, Hantouche E.

Encephale. 1989 May-Jun;15(3):325-33. Review. French.

PMID:
8641159
14.

[Effectiveness and tolerability of addition of risperidone in obsessive-compulsive disorder with poor response to serotonin reuptake inhibitors].

Arias Horcajadas F, Soto JA, García-Cantalapiedra MJ, Rodríguez Calvin JL, Morales J, Salgado M.

Actas Esp Psiquiatr. 2006 May-Jun;34(3):147-52. Spanish.

PMID:
16736387
15.

Pharmacotherapy for obsessive-compulsive disorder.

Dougherty DD, Rauch SL, Jenike MA.

J Clin Psychol. 2004 Nov;60(11):1195-202.

PMID:
15389617
16.
17.

Memantine augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial.

Aboujaoude E, Barry JJ, Gamel N.

J Clin Psychopharmacol. 2009 Feb;29(1):51-5. doi: 10.1097/JCP.0b013e318192e9a4.

PMID:
19142108
18.

A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder.

Matsunaga H, Nagata T, Hayashida K, Ohya K, Kiriike N, Stein DJ.

J Clin Psychiatry. 2009 Jun;70(6):863-8. doi: 10.4088/JCP.08m04369. Epub 2009 May 5.

PMID:
19422759
19.
20.

Obsessive-compulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome.

Perugi G, Toni C, Frare F, Travierso MC, Hantouche E, Akiskal HS.

J Clin Psychiatry. 2002 Dec;63(12):1129-34.

PMID:
12523872
Items per page

Supplemental Content

Write to the Help Desk